Actualizado 26/06/2009 11:09
- Comunicado -

Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on

Investors, Brad Cole, +1-650-569-2281, investors@genomichealth.com, or Media, Emily Faucette, +1-650-569-2824, media@genomichealth.com, both Genomic Health, Inc. / NOTE TO EDITORS: The Genomic Health logo, Oncotype, Oncotype DX and Recurrence Score are trademarks or registered trademarks of Genomic Health, Inc. All other trademarks and service marks are the property of their respective owners.

Contenido patrocinado